Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir Dipivoxil in Pediatric Chronic Hepatitis B
NCT00095121Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Jun 2004
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chronic Hepatitis B (CHB) comparing Adefovir Dipivoxil with Placebo (2 arms). Primary endpoint: Percentage of Participants With Serum HBV DNA < 1000 Copies/mL and Normal ALT at Week 48. Started Jun 2004; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00095121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095121.